Royal Fund Management, LLC Medtronic PLC Transaction History

Royal Fund Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$84.11 - $103.33 $12,195 - $14,982	-145 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$72.92 - $121.3 $729 - $1,213	-10 Reduced 6.45%	145 $13,000
Q4 2019 May 11, 2020	SELL	$104.49 - $114.54 $2,089 - $2,290	-20 Reduced 11.43%	155 $17,000
Q3 2019 May 08, 2020	BUY	$98.02 - $111.18 $3,136 - $3,557	32 Added 22.38%	175 $18,000
Q2 2019 May 08, 2020	SELL	$84.15 - $99.38 $1,935 - $2,285	-23 Reduced 13.86%	143 $13,000
Q1 2019 May 11, 2020	BUY	$82.45 - $93.79 $989 - $1,125	12 Added 7.79%	166 $15,000
Q4 2018 May 07, 2020	BUY	$85.8 - $99.49 $943 - $1,094	11 Added 7.69%	154 $14,000
Q3 2018 May 07, 2020	SELL	$85.91 - $99.17 $28,865 - $33,321	-336 Reduced 70.15%	143 $14,000
Q2 2018 May 07, 2020	BUY	$77.48 - $87.83 $16,503 - $18,707	213 Added 80.08%	479 $41,000
Q1 2018 May 07, 2020	BUY	$76.55 - $87.26 $20,362 - $23,211	266 New	266 $21,000
Q3 2017 May 07, 2020	SELL	$77.71 - $84.6 $5,750 - $6,260	-74 Closed	0 $0
Q2 2017 May 07, 2020	BUY	N/A	74	74 $6,000

2,289

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Fund Management, LLC with notifications on news.